< Back to search
Filter
1

Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell

for
Renal Cell Carcinoma (Kidney Cancer)
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT07062549

Phase1, Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

for
Melanoma, Non-small Cell Lung Cancer,
Location: Fairfax VA, Pittsburgh PA, Grand Rapids MI, St Louis MO,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07115043

Phase1, Phase2, Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

for
Hereditary Leiomyomatosis and Renal Cell Carcinoma,
Location: Bethesda MD, Columbus OH, Atlanta GA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT04981509

Phase2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

for
Borderline Resectable Pancreatic Ductal Adenocarcinoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07619313

Phase1, Recruiting

Interested in new metastatic pancreatic adenocarcinoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

for
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation,
Location: New York NY
Sponsor: General Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04150042

Phase1, Recruiting

Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma

for
Metastatic Pancreatic Ductal Adenocarcinoma,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT07096362

Phase2, Recruiting

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

for
Metastatic Pancreatic Ductal Adenocarcinoma,
Location: Miami FL
Sponsor: Benjamin Spieler

Sex: All

Age: 18+

Code: NCT06843551

Phase2, Recruiting

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), Cancer of Pancreas,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03977233

Phase2, Recruiting

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

for
Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06483555

Phase1, Phase2, Recruiting

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

for
Borderline Resectable Pancreatic Adenocarcinoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05688215

Phase1, Phase2, Recruiting

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer,
Location: Montreal
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07261631

Phase1, Recruiting

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

for
Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT04623502

Recruiting

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

for
Metastatic Renal Cell Carcinoma ( mRCC),
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT06601296

Phase2, Recruiting

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

for
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma,
Location: Boston MA, Philadelphia PA, Charlottesville VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04104776

Phase1, Phase2, Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

for
Endometrial Cancer, Metastasis, Endometrioid Endometrial Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: Female

Age: 18+

Code: NCT05542407

Phase1, Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer,
Location: Lake Success NY, Grand Rapids MI, Houston TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06242470

Phase1, Recruiting

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

for
Renal Cell Cancer, Castrate Resistant Prostate Cancer,
Location: Houston TX, Los Angeles CA
Sponsor: Portage Biotech

Sex: All

Age: 18+

Code: NCT04969315

Phase1, Phase2, Recruiting

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

for
Clear Cell Renal Cell Carcinoma
Location: New Haven CT, New York NY, New Brunswick NJ, Durham NC,
Sponsor: Xencor, Inc.

Sex: All

Age: 18+

Code: NCT05433142

Phase1, Recruiting

[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma
Location: Dallas TX
Sponsor: Orhan Kemal Oz

Sex: All

Age: 18+

Code: NCT04989959

Phase1, Recruiting